Group X sPLA2 activators comprise a spectrum of chemical entities specifically tailored to escalate the activity or expression of the enzyme secretory phospholipase A2 group X (sPLA2-X). This enzyme is a prominent member of the sPLA2 family, recognized for its aptitude in hydrolyzing phospholipids at the sn-2 position, leading to the production of free fatty acids and lysophospholipids. Due to this, sPLA2-X is often embedded in a web of biological processes, especially those tethered to lipid metabolism, inflammation, and signal transduction. Consequently, the activators of this enzyme tend to play pivotal roles in modulating these pathways, aiding in the dissection of the intricate maze of lipid-related cellular events.
The chemical framework of these activators is diverse, owing to the multifaceted nature of sPLA2-X interactions and its involvement in a range of cellular events. Some activators operate by bolstering the enzyme's stability, ensuring its prolonged presence and reinforced action within the cellular milieu. Others might be structured to stimulate cellular transcriptional or translational machinery, augmenting the expression of the sPLA2-X enzyme. Yet, certain compounds could interface directly with the enzyme, modifying its active site or allosteric sites, ensuring enhanced enzymatic activity. Furthermore, given the interplay of sPLA2-X with lipid metabolism and inflammation, many activators are deeply entrenched in these pathways, serving as crucial modulators. An in-depth understanding of these activators not only demystifies the world of lipid signaling but also paints a clearer picture of the molecular dynamics of cells. As science delves deeper into the realms of cellular signaling, the significance of these activators in delineating and deciphering lipid-related pathways becomes ever more pronounced.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Arachidonic Acid (20:4, n-6) | 506-32-1 | sc-200770 sc-200770A sc-200770B | 100 mg 1 g 25 g | $92.00 $240.00 $4328.00 | 9 | |
| Arachidonic Acid | 506-32-1 | Arachidonic acid, a precursor for eicosanoid synthesis, might stimulate pathways linked to sPLA2 expression as part of a feedback mechanism. | | ||||||
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
| Lipopolysaccharide (LPS) | 263-666-4 | LPS, known for inducing inflammatory pathways, could potentially boost the expression of sPLA2, given its role in inflammation. | | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
| Forskolin | 66575-29-9 | By elevating cAMP levels, Forskolin could activate pathways leading to increased sPLA2 expression. | | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
| Dexamethasone | 50-02-2 | This compound, influencing lipid metabolism and inflammation, may have an effect on sPLA2 expression. | | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
| Insulin | 9004-10-8 | Insulin can modulate lipid metabolism and might, in certain contexts, induce sPLA2 expression. | | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
| Retinoic Acid | 302-79-4 | As a regulator of gene expression and differentiation, retinoic acid may influence sPLA2 transcription. | | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
| 1,25-Dihydroxyvitamin D3 | 32222-06-3 | This active form of Vitamin D regulates several genes and may modulate sPLA2 expression in certain contexts. | | ||||||